Human amniotic membrane-derived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function

Cell Transplantation

Volumn 24, Issue 9, 2015, Pages 1733-1752

  Magatti, Marta ^a   Caruso, Maddalena ^a   De Munari, Silvia ^a   Vertua, Elsa ^a   De, Debashree ^a   Manuelpillai, Ursula ^b,c   Parolini, Ornella ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Amniotic epithelial cells (AECs); Amniotic mesenchymal stromal cells; Dendritic cells (DCs); Human placenta; Immunomodulation; Monocytes

Indexed keywords

CXCL9 CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CONDITIONED MEDIUM;

AMNION; AMNIOTIC EPITHELIAL CELL; AMNIOTIC MESENCHYMAL STROMA CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CULTURE MEDIUM; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MONOCYTE; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; COCULTURE; CONDITIONED MEDIUM; CYTOLOGY; IMMUNOASSAY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM;

AMNION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; EPITHELIAL CELLS; HUMANS; IMMUNOASSAY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMAL CELLS; MONOCYTES; T-LYMPHOCYTES;

EID: 84940766411     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X684033     Document Type: Article

References (81)

1. Albert, M. L.; Jegathesan, M.; Darnell, R. B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010–1017; 2001.
2. Alcaraz, A.; Mrowiec, A.; Insausti, C. L.; Garcia-Vizcaino, E. M.; Ruiz-Canada, C.; Lopez-Martinez, M. C.; Moraleda, J. M.; Nicolas, F. J. Autocrine TGF-beta induces epithelial to mesenchymal transition in human amniotic epithelial cells. Cell Transplant. 22:1351–1367; 2013.
3. Bailo, M.; Soncini, M.; Vertua, E.; Signoroni, P. B.; Sanzone, S.; Lombardi, G.; Arienti, D.; Calamani, F.; Zatti, D.; Paul, P.; Albertini, A.; Zorzi, F.; Cavagnini, A.; Candotti, F.; Wengler, G. S.; Parolini, O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78:1439–1448; 2004.
4. Banas, R.; Miller, C.; Guzik, L.; Zeevi, A. Amnion-derived multipotent progenitor cells inhibit blood monocyte differentiation into mature dendritic cells. Cell Transplant. 23(9):1111–1125; 2014.
5. Banas, R. A.; Trumpower, C.; Bentlejewski, C.; Marshall, V.; Sing, G.; Zeevi, A. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum. Immunol. 69:321–328; 2008.
6. Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y. J.; Pulendran, B.; Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767–811; 2000.
7. Banchereau, J.; Steinman, R. M. Dendritic cells and the control of immunity. Nature 392:245–252; 1998.
8. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214–2219; 2005.
9. Bilic, G.; Zeisberger, S. M.; Mallik, A. S.; Zimmermann, R.; Zisch, A. H. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 17:955–968; 2008.
10. Cargnoni, A.; Gibelli, L.; Tosini, A.; Signoroni, P. B.; Nassuato, C.; Arienti, D.; Lombardi, G.; Albertini, A.; Wengler, G. S.; Parolini, O. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin- induced lung fibrosis. Cell Transplant. 18:405–422; 2009.
11. Cargnoni, A.; Piccinelli, E. C.; Ressel, L.; Rossi, D.; Magatti, M.; Toschi, I.; Cesari, V.; Albertini, M.; Mazzola, S.; Parolini, O. Conditioned medium from amniotic membrane- derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cytotherapy 16:17–32; 2014.
12. Cargnoni, A.; Ressel, L.; Rossi, D.; Poli, A.; Arienti, D.; Lombardi, G.; Parolini, O. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 14:153–161; 2012.
13. Caruso, M.; Silini, A.; Parolini, O. The human amniotic membrane: A tissue with multifaceted properties and different potential clinical applications. In: Cetrulo, K.; Cetrulo, C. L., Jr.; Taghizadeh, R. R., eds. Perinatal stem cells. Hoboken, NJ: Wiley-Blackwell; 2013:177–195.
14. Chen, L.; Zhang, W.; Yue, H.; Han, Q.; Chen, B.; Shi, M.; Li, J.; Li, B.; You, S.; Shi, Y.; Zhao, R. C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev. 16:719–731; 2007.
15. Chomarat, P.; Banchereau, J.; Davoust, J.; Palucka, A. K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:510–514; 2000.
16. Cools, N.; Ponsaerts, P.; Van Tendeloo, V. F.; Berneman, Z. N. Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 82:1365–1374; 2007.
17. Covas, D. T.; Panepucci, R. A.; Fontes, A. M.; Silva, Jr., W. A.; Orellana, M. D.; Freitas, M. C.; Neder, L.; Santos, A. R.; Peres, L. C.; Jamur, M. C.; Zago, M. A. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36:642–654; 2008.
18. Diaz-Prado, S.; Muinos-Lopez, E.; Hermida-Gomez, T.; Rendal-Vazquez, M. E.; Fuentes-Boquete, I.; de Toro, F. J.; Blanco, F. J. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J. Cell. Biochem. 111:846–857; 2010.
19. Djouad, F.; Charbonnier, L. M.; Bouffi, C.; Louis-Plence, P.; Bony, C.; Apparailly, F.; Cantos, C.; Jorgensen, C.; Noel, D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025–2032; 2007.
20. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315– 317; 2006.
21. Dubois, B.; Bridon, J. M.; Fayette, J.; Barthelemy, C.; Banchereau, J.; Caux, C.; Briere, F. Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol. 66:224–230; 1999.
22. Dubois, B.; Caux, C. Critical role of ITIM-bearing FcgammaR on DCs in the capture and presentation of native antigen to B cells. Immunity 23:463–464; 2005.
23. Gerosa, F.; Gobbi, A.; Zorzi, P.; Burg, S.; Briere, F.; Carra, G.; Trinchieri, G. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174:727–734; 2005.
24. Gould, H. J.; Sutton, B. J. IgE in allergy and asthma today. Nat. Rev. Immunol. 8:205–217; 2008.
25. Groh, M. E.; Maitra, B.; Szekely, E.; Koc, O. N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 33:928–934; 2005.
26. Gu, L.; Tseng, S.; Horner, R. M.; Tam, C.; Loda, M.; Rollins, B. J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407–411; 2000.
27. Heath, W. R.; Belz, G. T.; Behrens, G. M.; Smith, C. M.; Forehan, S. P.; Parish, I. A.; Davey, G. M.; Wilson, N. S.; Carbone, F. R.; Villadangos, J. A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199:9–26; 2004.
28. Ilancheran, S.; Michalska, A.; Peh, G.; Wallace, E. M.; Pera, M.; Manuelpillai, U. Stem cells derived from human fetal membranes display multi-lineage differentiation potential. Biol. Reprod. 77:577–588; 2007.
29. Jiang, X. X.; Zhang, Y.; Liu, B.; Zhang, S. X.; Wu, Y.; Yu, X. D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120–4126; 2005.
30. Jonuleit, H.; Schmitt, E.; Schuler, G.; Knop, J.; Enk, A. H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213–1222; 2000.
31. Jung, S.; Unutmaz, D.; Wong, P.; Sano, G.; De los Santos, K.; Sparwasser, T.; Wu, S.; Vuthoori, S.; Ko, K.; Zavala, F.; Pamer, E. G.; Littman, D. R.; Lang, R. A. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211–220; 2002.
32. Kamiya, K.; Wang, M.; Uchida, S.; Amano, S.; Oshika, T.; Sakuragawa, N.; Hori, J. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Exp. Eye Res. 80:671–679; 2005.
33. Kang, J. W.; Koo, H. C.; Hwang, S. Y.; Kang, S. K.; Ra, J. C.; Lee, M. H.; Park, Y. H. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J. Vet. Sci. 13:23–31; 2012.
34. Krampera, M.; Glennie, S.; Dyson, J.; Scott, D.; Laylor, R.; Simpson, E.; Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722–3729; 2003.
35. Kronsteiner, B.; Peterbauer-Scherb, A.; Grillari-Voglauer, R.; Redl, H.; Gabriel, C.; van Griensven, M.; Wolbank, S. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell. Immunol. 267:30–38; 2011.
36. Langenkamp, A.; Messi, M.; Lanzavecchia, A.; Sallusto, F. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311–316; 2000.
37. La Rocca, G.; Corrao, S.; Lo Iacono, M.; Corsello, T.; Farina, F.; Anzalone, R. Novel immunomodulatory markers expressed by human WJ-MSC: An updated review in regenerative and reparative medicine. Open Tissue Eng. Regen. Med. J. 5:50–58; 2012.
38. La Rocca, G.; Lo Iacono, M.; Corsello, T.; Corrao, S.; Farina, F.; Anzalone, R. Human Wharton’s jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: New perspectives for cellular therapy. Curr. Stem Cell Res. Ther. 8:100–113; 2013.
39. LeibundGut-Landmann, S.; Gross, O.; Robinson, M. J.; Osorio, F.; Slack, E. C.; Tsoni, S. V.; Schweighoffer, E.; Tybulewicz, V.; Brown, G. D.; Ruland, J.; Reis e Sousa, C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630–638; 2007.
40. Li, H.; Niederkorn, J. Y.; Neelam, S.; Mayhew, E.; Word, R. A.; McCulley, J. P.; Alizadeh, H. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest. Ophthalmol. Vis. Sci. 46:900–907; 2005.
41. Li Pira, G.; Ivaldi, F.; Bottone, L.; Quarto, R.; Manca, F. Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells. Hum. Immunol. 67:976–985; 2006.
42. Liu, Y. H.; Vaghjiani, V.; Tee, J. Y.; To, K.; Cui, P.; Oh, D. Y.; Manuelpillai, U.; Toh, B. H.; Chan, J. Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One 7:e35758; 2012.
43. Luo, X.; Tarbell, K. V.; Yang, H.; Pothoven, K.; Bailey, S. L.; Ding, R.; Steinman, R. M.; Suthanthiran, M. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104:2821–2826; 2007.
44. Lutz, M. B.; Schuler, G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 23:445–449; 2002.
45. Mafi, P.; Hindocha, S.; Mafi, R.; Griffin, M.; Khan, W. S. Adult mesenchymal stem cells and cell surface characterization - A systematic review of the literature. Open Orthop. J. 5:253–260; 2011.
46. Magatti, M.; De Munari, S.; Vertua, E.; Gibelli, L.; Wengler, G. S.; Parolini, O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182–192; 2008.
47. Magatti, M.; De Munari, S.; Vertua, E.; Nassauto, C.; Albertini, A.; Wengler, G. S.; Parolini, O. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 18:899–914; 2009.
48. Magatti, M.; De Munari, S.; Vertua, E.; Parolini, O. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. J. Cell. Mol. Med. 16:2208–2218; 2012.
49. Mantovani, A.; Sica, A.; Locati, M. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37:14–16; 2007.
50. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686; 2004.
51. Manuelpillai, U.; Lourensz, D.; Vaghjiani, V.; Tchongue, J.; Lacey, D.; Tee, J. Y.; Murthi, P.; Chan, J.; Hodge, A.; Sievert, W. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis. PLoS One 7:e38631; 2012.
52. Manuelpillai, U.; Moodley, Y.; Borlongan, C. V.; Parolini, O. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 32 (Suppl 4):S320–S325; 2011.
53. Manuelpillai, U.; Tchongue, J.; Lourensz, D.; Vaghjiani, V.; Samuel, C. S.; Liu, A.; Williams, E. D.; Sievert, W. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl(4)-treated mice. Cell Transplant. 19:1157–1168; 2010.
54. Martinez, F. O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to- macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 177:7303–7311; 2006.
55. Melief, S. M.; Geutskens, S. B.; Fibbe, W. E.; Roelofs, H. Multipotent stromal cells skew monocytes towards an antiinflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica 98:888–895; 2013.
56. Miki, T.; Lehmann, T.; Cai, H.; Stolz, D. B.; Strom, S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549–1559; 2005.
57. Miki, T.; Marongiu, F.; Ellis, E.; Dorko, K.; Strom, S. Isolation of amniotic epithelial cells. Curr. Protoc. Stem Cells Biol. 2007:1E.3.1–1E.3.9; 2007.
58. Moodley, Y.; Ilancheran, S.; Samuel, C.; Vaghjiani, V.; Atienza, D.; Williams, E. D.; Jenkin, G.; Wallace, E.; Trounson, A.; Manuelpillai, U. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am. J. Respir. Crit. Care Med. 182:643–651; 2010.
59. Napolitani, G.; Rinaldi, A.; Bertoni, F.; Sallusto, F.; Lanzavecchia, A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:769–776; 2005.
60. Nauta, A. J.; Kruisselbrink, A. B.; Lurvink, E.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 177:2080–2087; 2006.
61. Parolini, O.; Alviano, F.; Bagnara, G. P.; Bilic, G.; Buhring, H. J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; Miki, T.; Marongiu, F.; Nakajima, H.; Nikaido, T.; Portmann-Lanz, C. B.; Sankar, V.; Soncini, M.; Stadler, G.; Surbek, D.; Takahashi, T. A.; Redl, H.; Sakuragawa, N.; Wolbank, S.; Zeisberger, S.; Zisch, A.; Strom, S. C. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first International Workshop on Placenta Derived Stem Cells. Stem Cells 26:300–311; 2008.
62. Parolini, O.; Alviano, F.; Betz, A. G.; Bianchi, D. W.; Gotherstrom, C.; Manuelpillai, U.; Mellor, A. L.; Ofir, R.; Ponsaerts, P.; Scherjon, S. A.; Weiss, M. L.; Wolbank, S.; Wood, K. J.; Borlongan, C. V. Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). Placenta 32(Suppl 4):S285–S290; 2011.
63. Parolini, O.; Caruso, M. Review: Preclinical studies on placenta-derived cells and amniotic membrane: An update. Placenta 32(Suppl 2):S186–S195; 2011.
64. Potian, J. A.; Aviv, H.; Ponzio, N. M.; Harrison, J. S.; Rameshwar, P. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171:3426–3434; 2003.
65. Pratama, G.; Vaghjiani, V.; Tee, J. Y.; Liu, Y. H.; Chan, J.; Tan, C.; Murthi, P.; Gargett, C.; Manuelpillai, U. Changes in culture expanded human amniotic epithelial cells: Implications for potential therapeutic applications. PLoS One 6:e26136; 2011.
66. Pulendran, B.; Smith, J. L.; Caspary, G.; Brasel, K.; Pettit, D.; Maraskovsky, E.; Maliszewski, C. R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036–1041; 1999.
67. Ramasamy, R.; Fazekasova, H.; Lam, E. W.; Soeiro, I.; Lombardi, G.; Dazzi, F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71–76; 2007.
68. Rossi, D.; Pianta, S.; Magatti, M.; Sedlmayr, P.; Parolini, O. Characterization of the conditioned medium from amniotic membrane cells: Prostaglandins as key effectors of its immunomodulatory activity. PLoS One 7:e46956; 2012.
69. Saeidi, M.; Masoud, A.; Shakiba, Y.; Hadjati, J.; Mohyeddin Bonab, M.; Nicknam, M. H.; Latifpour, M.; Nikbin, B. Immunomodulatory effects of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells. Iran J. Allergy Asthma Immunol. 12:37–49; 2013.
70. Sallusto, F.; Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109–1118; 1994.
71. Seder, R. A.; Paul, W. E.; Davis, M. M.; FazekasdeSt Groth, B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091–1098; 1992.
72. Silini, A.; Parolini, O.; Huppertz, B.; Lang, I. Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Curr. Stem Cell Res. Ther. 8:6–14; 2013.
73. Stadler, G.; Hennerbichler, S.; Lindenmair, A.; Peterbauer, A.; Hofer, K.; van Griensven, M.; Gabriel, C.; Redl, H.; Wolbank, S. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy 10:743–752; 2008.
74. Steinman, R. M.; Banchereau, J. Taking dendritic cells into medicine. Nature 449:419–426; 2007.
75. Takeya, M.; Tsuchiya, T.; Shimokawa, Y.; Takahashi, K. A new monoclonal antibody, PM-2K, specifically recognizes tissue macrophages but not blood monocytes. J. Pathol. 163:315–321; 1991.
76. Tee, J. Y.; Vaghjiani, V.; Liu, Y. H.; Murthi, P.; Chan, J.; Manuelpillai, U. Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells. Curr. Stem Cell Res. Ther. 8:91–99; 2013.
77. Van Ginderachter, J. A.; Movahedi, K.; Hassanzadeh Ghassabeh, G.; Meerschaut, S.; Beschin, A.; Raes, G.; DeBaetselier, P. Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion. Immunobiology 211:487–501; 2006.
78. Ventura, C.; Cantoni, S.; Bianchi, F.; Lionetti, V.; Cavallini, C.; Scarlata, I.; Foroni, L.; Maioli, M.; Bonsi, L.; Alviano, F.; Fossati, V.; Bagnara, G. P.; Pasquinelli, G.; Recchia, F. A.; Perbellini, A. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J. Biol. Chem. 282:14243–4252; 2007.
79. Wei, J. P.; Nawata, M.; Wakitani, S.; Kametani, K.; Ota, M.; Toda, A.; Konishi, I.; Ebara, S.; Nikaido, T. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells 11:19–26; 2009.
80. Wolbank, S.; Peterbauer, A.; Fahrner, M.; Hennerbichler, S.; van Griensven, M.; Stadler, G.; Redl, H.; Gabriel, C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 13:1173–1183; 2007.
81. Zhang, W.; Ge, W.; Li, C.; You, S.; Liao, L.; Han, Q.; Deng, W.; Zhao, R. C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocytederived dendritic cells. Stem Cells Dev. 13:263–271; 2004.